Clinical Trial Update: Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluates stereotactic body radiation therapy with or without nivolumab for patients with Stage I-IIA or recurrent non-small cell lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Carcinoid Tumor of the Lung
• Large Cell Lung Carcinoma
• Lung Adenocarcinoma
• Lung Neuroendocrine Carcinoma
• Lung Neuroendocrine Tumor
• Lung Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Non-small Cell Lung Carcinoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Atypical Carcinoid Tumor, Lung Neuroendocrine Neoplasm | Phase 2 | Status: ACTIVE_NOT_RECRUITING